Your browser doesn't support javascript.
loading
Does preoperative CA-125 cutoff value and percent reduction in CA-125 levels correlate with surgical and survival outcome after neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer? - Our experience from a tertiary cancer institute.
Gupta, Monisha; Patel, Shilpa Mukesh; Arora, Ruchi; Tiwari, Rajneesh; Dave, Pariseema; Desai, Ava; Mankad, Meeta.
Affiliation
  • Gupta M; Department of Gynecology Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
  • Patel SM; Department of Gynecology Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
  • Arora R; Department of Gynecology Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
  • Tiwari R; Department of Gynecology Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
  • Dave P; Department of Gynecology Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
  • Desai A; Department of Gynecology Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
  • Mankad M; Department of Gynecology Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
South Asian J Cancer ; 9(1): 30-33, 2020.
Article in En | MEDLINE | ID: mdl-31956617

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: South Asian J Cancer Year: 2020 Type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: South Asian J Cancer Year: 2020 Type: Article Affiliation country: India